David-Alexandre C Gros
CIK 1644489 · Chief Executive Officer · last filed 2025-01-13
David-Alexandre C Gros is a Chief Executive Officer who has filed 16 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for ELDN, was dated Jan 13, 2025. Across all open-market trades the lifetime net is +$120.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $315.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$315.0K
4
16
$120.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELDN | Chief Executive Officer | 9,000 | $3.57 | $32.1K | $57.8K | 9 | 2025-01-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Chief Executive Officer | — | — | — | $0 | 1 | 2020-09-15 |
| NBIX | President & COO | — | $159.76 | — | $0 | 2 | 2017-02-08 |
| ALNY | SVP, Chief Business Officer | 1,000 | $282.85 | $282.9K | $62.7K | 4 | 2016-12-22 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-13 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2024-11-22 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2023-05-02 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2023-02-02 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | ELDN | Grant (A) | — | $0 | EDGAR |
| 2021-12-21 | ELDN | Buy (P) | +2,000 | $9.0K | EDGAR |
| 2021-08-19 | ELDN | Buy (P) | +4,000 | $24.8K | EDGAR |
| 2021-06-10 | ELDN | Buy (P) | +3,000 | $24.0K | EDGAR |
| 2020-09-15 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Grant (A) | — | $0 | EDGAR |